InvestorsHub Logo
icon url

IgnoranceIsBliss

05/24/20 8:53 AM

#275974 RE: ziploc_1 #275973

All that is true, and we villified his actions here, but I thought that recently he had begun to climb onto the Vascepa bandwagon.

I'm remembering a video where he was doing a decent amount of Bhattkissing -- I think they were sitting together on a panel.
icon url

garynavarre

05/24/20 9:38 AM

#275982 RE: ziploc_1 #275973

I wonder if Dr. Nissen wants to revive the fortunes of Omacor. They stopped the Strength Trial because of the superiority of Vascepa. If Amarin loses the appeal, maybe he sees an opening in the CV field. If a Covid-19 trial of Omacor proves that it works for that indication, that would help their cause. A 13,000 patient trial of Omacor has more chance of a statistical significant finding than Amarin's 200 patient trial in Canada (which is the only one that I am familiar with (although Amarin said that there are several studies being done).
icon url

HDGabor

05/24/20 11:55 AM

#275995 RE: ziploc_1 #275973

He was a lead investigator in the failed Omacor STRENGTH trial in which Astra Zeneca

Omacor??!!! Gees … How about Epanova?

A long-time Amarin poster has no clue about competitors but Judge Du "called out" due to "fish oil" comment … (which was not a mistake … but a lot of posters are biased … Vascepa is fish oil acc. to Amarin - see ITC Complaint - but is not the same as COMMON fish oil).
icon url

Meowza

05/24/20 12:26 PM

#276003 RE: ziploc_1 #275973

Amazing how certain people make the leap from "won't work, it's just fish oil" to "of course, we always knew about fish oil". No matter how consistently V uniquely splits arrows on the bull's eye. Too bad V doesn't work on pigheaded cynics.